RE:A subtle change in wording from most recent PR...From a business standpoint, consolidation is more alikened to two different companies doing the same thing so why not consolidate, grow organically while consolidating operations to reduce costs and increase profits. I see wonderful 'consolidation' opportunity between 2 CDMO companies being PC1 divisioin of Pfizer and Medipharm Labs because fundamentally, albeit on different scales of size, they do the same thing. And make no mistake, the PC1 division does have a type of mentoring program, no different than Avicanna being a spin out from JLABS. And one last point, "the industry"....LABS is in the pharmaceutical industry segment, not recreational.
"thoughtfully consider"....a good CEO will consider what gives shareholders the best return on their investment.
A JV and I'm sticking to that until the CEO proves me wrong because the Keepers have indicated to me repeatedly that course of action.